---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-010006"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T16:43:44.907202+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Solutions Q3 revenue $0.73M, up 20% QoQ; gross profit up 91% YoY

## Summary
- Revenue $0.73M in fiscal Q3, up 20% sequentially; nine-month revenue $2.21M, down 7% YoY.
- Gross profit $341,368, up 91% YoY; cartridge sales now 58% of total revenue for nine months.
- Net loss attributable to company $2.54M, down from $2.98M YoY; cash $2.81M.
- Added 35 new accounts in Q3, active customers exceed 450; launched multilingual system upgrades.

## SEC filing metadata
- accession: 0001641172-25-010006
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000164117225010006/0001641172-25-010006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000164117225010006/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-010006
- JSON: https://secwatch.observer/filing/0001641172-25-010006.json
- Plain text: https://secwatch.observer/filing/0001641172-25-010006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.